VVOS · Forms 3, 4, 5
Insider trades at Vivos Therapeutics, Inc.
No open-market insider buys or sells at Vivos Therapeutics, Inc. in the last 90 days; 4 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Vivos Therapeutics, Inc. (VVOS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Leonard J Sokolow | Director | Options or other derivatives | Form 4 | ||||
| Gregg C Johnson | Director | Options or other derivatives | Form 4 | ||||
| Bradford K. Amman | Principal Accounting Officer | Award | 250,000 | $0.41 | $103K | Form 4 | |
| Ronald Kirk Huntsman | Chief Executive Officer | Other | 85,910 | $0.58 | $50K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.